- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02697942
Hemodialysis-based Interventions to Preserve Cognitive Function
April 17, 2018 updated by: Johns Hopkins Bloomberg School of Public Health
This will be a pilot, single center, randomized, controlled trial to slow cognitive decline in adults undergoing hemodialysis (HD).
The investigators will test two interventions (cognitive training and exercise training) against the standard of care.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
This will be a pilot, single center, randomized, controlled trial to slow cognitive decline in adults undergoing hemodialysis (HD).
The investigators primary objective is to demonstrate feasibility for the interventions (cognitive training and exercise training) in Aim 1.
The investigators will formally test whether whether cognitive training (tablet-based brain games) and exercise training (stationary foot pedal) administered during HD slow cognitive decline as well as improve secondary outcomes (physical function, frailty, and health-related quality of life (HRQOL) as part of Aim 2. The investigators will compare these two interventions against the standard of care.
Pre- and post-intervention assessments will be conducted at the dialysis unit by a study coordinator and by research assistants.
Participants will be followed for 6 months to assess cognitive decline.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21231
- Bond St DaVita Dialysis Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Men and women with end stage renal disease and receiving hemodialysis at the DaVita Dialysis Centers located at 409 N. Caroline St., Baltimore, MD will be approached by our study coordinator to determine eligibility.
- Must be at least 18 years or older at enrollment
- Must be English speaking
- Must be willing to participate in research and able to give informed consent
Exclusion Criteria:
- Chronic lung disease requiring oxygen
- Cerebrovascular disease
- Musculoskeletal conditions that limit mobility
- Lower or upper extremity amputation
- Orthopedic disorders exacerbated by physical activity
- Decreased mental capacity
- Dementia (diagnosed)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard of care
Participants randomized to the standard of care arm will not receive any intervention.
|
|
Experimental: Cognitive training (CT)
Participants randomized to the CT arm will be given a tablet with connection to Lumosity®, which is a web-based "brain game".
Participants will use the tablets to play brain games at each dialysis session.
|
The investigators will provide participants with tablets to play brain games through Lumosity.
|
Active Comparator: Exercise training (ET)
Participants randomized to ET arm will be given a stationary foot peddler.
This foot peddler will be situated at a comfortable distance from the dialysis chair so that the patient can comfortably reach the peddler.
Participants will use the foot peddlers at each dialysis session.
|
The investigators will provide participants with foot peddlers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive function measured using the Modified Mini Mental Status
Time Frame: 6 months post-intervention
|
Cognitive decline assessed as both the change in Modified Mini Mental Status and Trail making Test A and B scores as well as 10% decline in these measures of cognitive function
|
6 months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
physical function measured using the Short Physical Performance Battery (SPBB)
Time Frame: 6 months post-intervention
|
SPBB score of <10 considered as physical function impaired
|
6 months post-intervention
|
Fried frailty phenotype
Time Frame: 6 months post-intervention
|
Defined by the presence of 3 or more of the following: slowed walking speed, low physical activity, exhaustion, poor grip strength, and low physical activity.
This is a binary outcome
|
6 months post-intervention
|
health-related quality of life (HRQOL)
Time Frame: 6 months post-intervention
|
measured by the Kidney Disease Quality of Life Scale
|
6 months post-intervention
|
Cognitive function
Time Frame: 6 months post-intervention
|
measured using the Trails Making Test A and B
|
6 months post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mara McAdams DeMarco, PhD, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2016
Primary Completion (Actual)
July 1, 2017
Study Completion (Actual)
November 20, 2017
Study Registration Dates
First Submitted
February 9, 2016
First Submitted That Met QC Criteria
February 26, 2016
First Posted (Estimate)
March 3, 2016
Study Record Updates
Last Update Posted (Actual)
April 19, 2018
Last Update Submitted That Met QC Criteria
April 17, 2018
Last Verified
April 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00006466
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Failure, Chronic
-
Centre Hospitalier Universitaire DijonTerminatedEnd-stage Chronic Kidney FailureFrance
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
Baxter Healthcare CorporationRecruitingAcute Kidney Failure | Chronic Kidney FailureChina
-
Angiodynamics, Inc.TerminatedChronic Kidney Disease | Acute Kidney Injury | Acute Renal Failure | Renal Failure Chronic Contrast InducedUnited States
-
Hopital Jean MinjozUnknownCardiac Surgical Procedures | Preoperative KIDNEY FAILURE, CHRONIC | Postoperative KIDNEY FAILURE, ACUTEFrance
-
University of WashingtonJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsRecruitingChronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditionsUnited States
-
Pharmagest InteractiveCompletedChronic Kidney DiseasesFrance
-
Bristol-Myers SquibbCompletedKidney Transplantation | Chronic Kidney FailureUnited States, Argentina, Australia, Germany, Italy, South Africa, Spain, Brazil, Mexico, Belgium, France, Hungary, Switzerland, India, Canada, Austria, Czech Republic, Poland, Israel, Sweden, Turkey
-
Emory UniversityGenentech, Inc.TerminatedKidney Transplantation | Chronic Kidney FailureUnited States
-
Ozge AKBABAAtaturk UniversityCompletedChronic Kidney FailureTurkey
Clinical Trials on cognitive training
-
Science and Research Centre KoperAlbert Einstein College of Medicine; University of Primorska; Vrije Universiteit...CompletedEffects of Cognitive Intervention on Cognition, Mobility and Brain Electrocortical Activity (GIBKOP)Cognitive Impairment | Aging | Cognitive Decline | Motor Coordination or FunctionSlovenia
-
Hospital de Clinicas de Porto AlegreYale UniversityUnknownAttention-deficit/Hyperactivity Disorder.Brazil
-
Universidade Federal do Rio de JaneiroUnknown
-
Chang Gung Memorial HospitalRecruitingVirtual Reality | Community-dwelling ElderlyTaiwan
-
Xuanwu Hospital, BeijingRecruitingMild Cognitive ImpairmentChina
-
Fundació Sant Joan de DéuCompletedIndication for Modification of Patient Cognitive StatusSpain
-
Chiang Mai UniversityCompletedMild Cognitive ImpairmentThailand
-
Chang Gung Memorial HospitalRecruitingMCI | SCD | Virtual RealityTaiwan
-
University of California, San FranciscoCompletedSchizophrenia | PsychosisUnited States
-
VA Office of Research and DevelopmentCompleted